产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 5mg | 98% | 现货 | |||
| 10mg | 98% | 现货 | |||
| 25mg | 98% | 现货 | |||
| 50mg | 98% | 现货 | |||
| 100mg | 98% | 现货 | |||
| 250mg | 98% | 现货 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 5mg | 98% | 现货 | |||
| 10mg | 98% | 现货 | |||
| 25mg | 98% | 现货 | |||
| 50mg | 98% | 现货 | |||
| 100mg | 98% | 现货 | |||
| 250mg | 98% | 现货 |
CAS No. |
2169919-21-3 |
|---|---|
中文名称 |
N-乙基-2-((4-(7-((反式-4-(乙基磺酰胺基)环己基)甲基)-2,7-二氮杂螺[3.5]壬烷-2-基)嘧啶-5-基)氧基)-5-氟-N-异丙基苯甲酰胺 |
英文名称 |
N-Ethyl-2-((4-(7-((trans-4-(ethylsulfonamido)cyclohexyl)methyl)-2,7-diazaspiro[3.5]nonan-2-yl)pyrimidin-5-yl)oxy)-5-fluoro-N-isopropylbenzamide |
别名 |
SNDX-5613 | revumenib | 2169919-21-3 | LZ0M43NNF2 | SNDX5613 | N-Ethyl-2-[4-[7-[[4-(ethylsulfonylamino)cyclohexyl]methyl]-2,7-diazaspiro[3.5]nonan-2-yl]pyrimidin-5-yl]oxy-5-fluoro-N-propan-2-ylbenzamide | 2-({4-[7-({(1r,4r)-4-[(ethanesulfonyl)amino]cyclohexyl}methyl) |
标准英文名 |
N-ethyl-2-((4-(7-(((1r,4r)-4-(ethylsulfonamido)cyclohexyl)methyl)-2,7-diazaspiro[3.5]nonan-2-yl)pyrimidin-5-yl)oxy)-5-fluoro-N-isopropylbenzamide |
分子式 |
C32H47FN6O4S |
分子量 |
630.83 |
精确分子量 |
630.34 |
SMILES |
C(N1CCC2(CN(C2)C=3C(OC4=C(C(N(C(C)C)CC)=O)C=C(F)C=C4)=CN=CN3)CC1)[C@@H]5CC[C@@H](NS(CC)(=O)=O)CC5 |
标准SMILES |
CC(C)N(CC)C(=O)C1C=C(F)C=CC=1OC1=CN=CN=C1N1CC2(C1)CCN(C[C@@H]1CC[C@H](CC1)NS(=O)(=O)CC)CC2 |
性状 |
Solid |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Warning |
InChIKey |
FRVSRBKUQZKTOW-YOCNBXQISA-N |
危险类别(旧) |
H302,H315,H319 |
存储要求 |
Sealed in dry,2-8°C,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral (Category 4),Skin corrosion/irritation (Category 2),Serious eye damage/eye irritation (Category 2A ) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|